Table 7 Sick-leave and hospital admissions in triptan non-users and in users without and with overuse
From: Use and overuse of triptans in Austria – a survey based on nationwide healthcare claims data
Triptan non-users n = 5,885,425 | Triptan users without overuse n = 31,092 | Triptan users with overuse n = 1970 | |||||||
|---|---|---|---|---|---|---|---|---|---|
Median | Q1 | Q3 | Median | Q1 | Q3 | Median | Q1 | Q3 | |
Sick-leave for | |||||||||
any reason (days) | 10 | 4 | 23 | 12 | 5 | 29 | 12 | 5 | 27.3 |
migraine (days) | 2 | 1 | 4 | 3 | 1 | 7 | 4 | 1 | 9 |
n | % | n | % | OR (CI)a | n | % | OR (CI)# | ||
Hospital admissions | 1,124,587 | 19.1 | 6082 | 19.6 | 1.0 (1.0–1.1) | 386 | 19.6 | 1.0 (0.9–1.1) | |